Back

Border control strategies for reducing importation risk of Clade Ib Mpox

Jin, S.; Guan, T.; Endo, A.; Gan, G.; Janhavi, A.; Hu, G.; Ejima, K.; Lim, J. T.; Dickens, B. L.

2024-09-10 infectious diseases
10.1101/2024.09.10.24313380 medRxiv
Show abstract

BackgroundThe Clade Ib monkeypox virus (MPXV), newly identified in the ongoing 2024 mpox outbreak, can be more transmissible through non-sexual routes compared to the previous Clade IIb strain. With imported cases sporadically reported globally, concerns have emerged about the potential of widespread transmission in the general community after importation events. Border control measures, such as screening and quarantining of arriving travellers, may help mitigate this risk and prevent localized outbreaks in the event of global spread. MethodsWe proposed nine border control strategies and evaluated their effectiveness in reducing importation risk using 10,000 microsimulations of individual infection profiles and PCR testing results under scenarios with varying disease prevalence levels (0.01%, 0.05%, and 0.1%) in the country of origin. ResultsThe proposed border-control measures would reduce missed cases by 40.1% (39.1%-41.0%), 49.8% (48.8%-50.8%), and 58.1% (57.1%-59.0%) for predeparture, on-arrival, and both tests, respectively. Replacing the on-arrival test with a seven-day quarantine and post-quarantine testing would lower the count to 21.8% (20.9%-22.6%). Quarantine-only strategies showed a linear increase in effectiveness against duration, reaching a 90.4% (89.8%-91.0%) reduction with a 28-day quarantine. Disparities in distributions of missed case counts across strategies would become more pronounced at higher prevalence levels, with stringent approaches like quarantining followed by post-quarantine screening and 28-day quarantine keeping counts below two per 10,000 travellers, even at 0.1% prevalence. ConclusionsWhen disease prevalence in the country of origin is low (0.01%), less restrictive approaches such as single on-arrival testing or a 14-day quarantine can maintain very low imported case counts of one or below. At higher prevalences, seven-day quarantining followed by post-quarantine testing, or 28-day quarantining is required to maintain similar effects. Decision makers will face balancing importation risk management and the negative impacts of such interventions to maintain safe international travel.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Travel Medicine
18 papers in training set
Top 0.1%
18.4%
2
The Lancet Infectious Diseases
71 papers in training set
Top 0.1%
14.2%
3
Emerging Infectious Diseases
103 papers in training set
Top 0.1%
9.0%
4
Eurosurveillance
80 papers in training set
Top 0.2%
4.8%
5
The Lancet Microbe
43 papers in training set
Top 0.1%
4.8%
50% of probability mass above
6
Clinical Infectious Diseases
231 papers in training set
Top 1%
4.8%
7
Nature Communications
4913 papers in training set
Top 38%
3.8%
8
BMC Medicine
163 papers in training set
Top 2%
2.8%
9
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.1%
2.7%
10
Annals of Internal Medicine
27 papers in training set
Top 0.2%
2.6%
11
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 2%
2.4%
12
One Health
29 papers in training set
Top 0.5%
1.9%
13
PLOS ONE
4510 papers in training set
Top 51%
1.9%
14
eLife
5422 papers in training set
Top 45%
1.5%
15
Nature Medicine
117 papers in training set
Top 3%
1.5%
16
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
1.3%
17
BMC Infectious Diseases
118 papers in training set
Top 4%
1.2%
18
Epidemics
104 papers in training set
Top 1%
0.9%
19
The Lancet
16 papers in training set
Top 0.5%
0.9%
20
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.9%
21
PLOS Medicine
98 papers in training set
Top 4%
0.9%
22
Open Forum Infectious Diseases
134 papers in training set
Top 2%
0.8%
23
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.5%
0.8%
24
New England Journal of Medicine
50 papers in training set
Top 0.8%
0.7%
25
Science
429 papers in training set
Top 20%
0.7%
26
Virus Evolution
140 papers in training set
Top 1%
0.7%
27
The Lancet Global Health
24 papers in training set
Top 1%
0.7%
28
Vaccine
189 papers in training set
Top 2%
0.7%
29
International Journal of Molecular Sciences
453 papers in training set
Top 18%
0.6%
30
International Journal of Environmental Research and Public Health
124 papers in training set
Top 8%
0.6%